These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 17400175)
21. Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D. Anderson PH; O'Loughlin PD; May BK; Morris HA J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):111-3. PubMed ID: 15225756 [TBL] [Abstract][Full Text] [Related]
23. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels. Anderson PH; O'Loughlin PD; May BK; Morris HA Bone; 2005 Apr; 36(4):654-62. PubMed ID: 15781002 [TBL] [Abstract][Full Text] [Related]
25. Leptin blocks the inhibitory effect of vitamin D on adipogenesis and cell proliferation in 3T3-L1 adipocytes. Nobre JL; Lisboa PC; Carvalho JC; Martins MR; Vargas S; Barja-Fidalgo C; de Moura EG; de Oliveira E Gen Comp Endocrinol; 2018 Sep; 266():1-8. PubMed ID: 29339180 [TBL] [Abstract][Full Text] [Related]
26. Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. van Driel M; Koedam M; Buurman CJ; Hewison M; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP FASEB J; 2006 Nov; 20(13):2417-9. PubMed ID: 17023519 [TBL] [Abstract][Full Text] [Related]
27. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Atkins GJ; Anderson PH; Findlay DM; Welldon KJ; Vincent C; Zannettino AC; O'Loughlin PD; Morris HA Bone; 2007 Jun; 40(6):1517-28. PubMed ID: 17395559 [TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Perwad F; Zhang MY; Tenenhouse HS; Portale AA Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1577-83. PubMed ID: 17699549 [TBL] [Abstract][Full Text] [Related]
29. Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. Yoshida T; Fujimori T; Nabeshima Y Endocrinology; 2002 Feb; 143(2):683-9. PubMed ID: 11796525 [TBL] [Abstract][Full Text] [Related]
30. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas. Jones G; Ramshaw H; Zhang A; Cook R; Byford V; White J; Petkovich M Endocrinology; 1999 Jul; 140(7):3303-10. PubMed ID: 10385427 [TBL] [Abstract][Full Text] [Related]
31. Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer. Blomberg Jensen M; Andersen CB; Nielsen JE; Bagi P; Jørgensen A; Juul A; Leffers H J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):376-82. PubMed ID: 20362668 [TBL] [Abstract][Full Text] [Related]
32. A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells. Lechner D; Manhardt T; Bajna E; Posner GH; Cross HS J Pharmacol Exp Ther; 2007 Mar; 320(3):1119-26. PubMed ID: 17182978 [TBL] [Abstract][Full Text] [Related]
33. Specific regulation of CYP27B1 and VDR in proximal versus distal renal cells. Bajwa A; Forster MN; Maiti A; Woolbright BL; Beckman MJ Arch Biochem Biophys; 2008 Sep; 477(1):33-42. PubMed ID: 18593564 [TBL] [Abstract][Full Text] [Related]
34. Evidence for protein kinase C involvement in the regulation of renal 25-hydroxyvitamin D3-24-hydroxylase. Mandla S; Boneh A; Tenenhouse HS Endocrinology; 1990 Dec; 127(6):2639-47. PubMed ID: 2174334 [TBL] [Abstract][Full Text] [Related]